Status:
UNKNOWN
Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection
Lead Sponsor:
Hopital Foch
Conditions:
Lung Cancer, Non-small Cell
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bronchopulmonary cancer, with 39 000 new cases and 30 000 deaths per year, is a main issue in public health in France. It is the leading cause of cancer death in France. A lot of progress in medical c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient aged ≥ 18 years old
- Patient with non-small cell lung cancer
- Operable grade I or II
- No specific treatment before surgery (radiotherapy, chemotherapy or targeted therapy)
- Patient with healthcare insurance
- Non Inclusion Criteria:
- Treatment with radiotherapy, chemotherapy, or neoadjuvant cancer targeted therapy before thoracic surgery
- Patient with oxygen therapy or invasive ventilation
- Patient unable to perform a slow vital capacity
- Dermatological therapy interfering with sweat collection (psoriasis, irritant dermatitis, for instance)
- Pregnant women
- Patient deprived of liberty by judicial or administrative decision
Exclusion
Key Trial Info
Start Date :
September 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03803137
Start Date
September 20 2018
End Date
September 1 2021
Last Update
December 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Foch
Suresnes, France, 92150